Found: 45
Select item for more details and to access through your institution.
Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: results of a European, multicenter cohort study.
- Published in:
- Supportive Care in Cancer, 2014, v. 22, n. 2, p. 417, doi. 10.1007/s00520-013-1991-4
- By:
- Publication type:
- Article
Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosing.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 5, p. 750, doi. 10.1002/ajh.26895
- By:
- Publication type:
- Article
Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.703233
- By:
- Publication type:
- Article
P-131: Use of the European Organisation for research and treatment of cancer quality of life Multiple Myeloma questionnaire (EORTC QLQ-MY20): a review of the literature 25 years after development.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S106, doi. 10.1016/S2152-2650(21)02258-8
- By:
- Publication type:
- Article
P-129: Quality of life reported outcomes in published research on AL Amyloidosis: a systematic literature review.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S105, doi. 10.1016/S2152-2650(21)02256-4
- By:
- Publication type:
- Article
P-039: Adaptation of a myeloma minimal residual disease multi-parametric flow assay for real world practice.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S59, doi. 10.1016/S2152-2650(21)02173-X
- By:
- Publication type:
- Article
OAB-060: Prospective comparison of contemporary whole body MRI and FDG PET/CT for disease detection and correlation with markers of disease burden in myeloma: results of the iTIMM trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S37, doi. 10.1016/S2152-2650(21)02132-7
- By:
- Publication type:
- Article
OAB-047: Plasma cell disorder patients are left vulnerable after one dose of the BNT162b2 mRNA or the ChAdOx-nCOV-19 COVID-19 vaccines.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S30, doi. 10.1016/S2152-2650(21)02121-2
- By:
- Publication type:
- Article
Ixazomib, lenalidomide and dexamethasone in relapsed AL amyloidosis – a first report.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e309, doi. 10.1016/j.clml.2019.09.508
- By:
- Publication type:
- Article
Real World Use of Ixazomib With Lenalidomide and Dexamethasone for Patients With Relapsed Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e264, doi. 10.1016/j.clml.2019.09.436
- By:
- Publication type:
- Article
European Post-Authorization Safety Study of Patients With Relapsed or Refractory Multiple Myeloma Treated With Pomalidomide in a Real-World Setting.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e256, doi. 10.1016/j.clml.2019.09.423
- By:
- Publication type:
- Article
Comparison of PET Reconstruction Algorithms on Assessment and Quantification of FDG-PETCT Findings in Patients with Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e171, doi. 10.1016/j.clml.2019.09.286
- By:
- Publication type:
- Article
Real World Data of the Impact of first cycle Daratumumab on Multiple Myeloma and Amyloidosis Services.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e157, doi. 10.1016/j.clml.2017.03.284
- By:
- Publication type:
- Article
European Post-Approval Safety Study (EU Pass) of Relapsed/Refractory Multiple Myeloma (RRMM): Safety In Patients (Pts) Treated With Pomalidomide (POM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e62, doi. 10.1016/j.clml.2017.03.113
- By:
- Publication type:
- Article
Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Is balloon kyphoplasty safe and effective for cancer-related vertebral compression fractures with posterior vertebral body wall defects?
- Published in:
- Journal of Surgical Oncology, 2016, v. 113, n. 7, p. 835, doi. 10.1002/jso.24222
- By:
- Publication type:
- Article
International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00717-2
- By:
- Publication type:
- Article
Low-dose thalidomide in combination with oral weekly cyclophosphamide and pulsed dexamethasone is a well tolerated and effective regimen in patients with relapsed and refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2005, v. 129, n. 6, p. 763, doi. 10.1111/j.1365-2141.2005.05521.x
- By:
- Publication type:
- Article
Systematic literature review of quality‐of‐life questionnaires in Waldenström macroglobulinaemia—need for a disease‐specific tool.
- Published in:
- EJHaem, 2023, v. 4, n. 2, p. 555, doi. 10.1002/jha2.668
- By:
- Publication type:
- Article
Patient reported outcome measures in Waldenström macroglobulinaemia: A real‐world data analysis from the WMUK Rory Morrison Registry.
- Published in:
- EJHaem, 2023, v. 4, n. 1, p. 221, doi. 10.1002/jha2.640
- By:
- Publication type:
- Article
Bortezomib‐based therapy is effective and well tolerated in frontline and multiply pre‐treated Waldenström macroglobulinaemia including BTKi failures: A real‐world analysis.
- Published in:
- EJHaem, 2022, v. 3, n. 4, p. 1330, doi. 10.1002/jha2.597
- By:
- Publication type:
- Article
Plasmablastic myeloma progressed to plasma cell leukaemia.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
International validation of two EORTC questionnaires for assessment of health‐related quality of life for patients with high‐grade non‐Hodgkin lymphoma (QLQ‐NHL‐HG29) and low‐grade non‐Hodgkin lymphoma (QLQ‐NHL‐LG20)
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 17, p. 2727, doi. 10.1002/cncr.34822
- By:
- Publication type:
- Article
Clinical and clonal characteristics of monoclonal immunoglobulin M‐associated type I cryoglobulinaemia.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 1, p. 177, doi. 10.1111/bjh.19112
- By:
- Publication type:
- Article
Is there a representative quality‐of‐life questionnaire for patients with AL amyloidosis?—systematic literature review.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 289, doi. 10.1111/bjh.18860
- By:
- Publication type:
- Article
The Rory Morrison WMUK Registry for Waldenström macroglobulinaemia: The growth of a national registry for a rare disorder.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 5, p. 905, doi. 10.1111/bjh.18680
- By:
- Publication type:
- Article
A UK consensus algorithm for early treatment modification in newly diagnosed systemic light‐chain amyloidosis.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 2, p. 328, doi. 10.1111/bjh.18216
- By:
- Publication type:
- Article
International validation of the EORTC QLQ‐CLL17 questionnaire for assessment of health‐related quality of life for patients with chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 4, p. 431, doi. 10.1111/bjh.18072
- By:
- Publication type:
- Article
Diagnosis and management of Waldenström macroglobulinaemia—A British Society for Haematology guideline.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 2, p. 171, doi. 10.1111/bjh.18036
- By:
- Publication type:
- Article
Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV‐19 COVID‐19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 3, p. e21, doi. 10.1111/bjh.17864
- By:
- Publication type:
- Article
Development of antibody response to SARS‐CoV‐2 following asymptomatic infection in patients with plasma cell disorders on immunomodulatory therapy.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 5, p. 857, doi. 10.1111/bjh.17441
- By:
- Publication type:
- Article
DT‐PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous stem cell transplantation.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. e73, doi. 10.1111/bjh.17248
- By:
- Publication type:
- Article
Association of hypertension and cardiac events in patients with multiple myeloma receiving carfilzomib: practical management recommendations.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 5, p. e312, doi. 10.1111/bjh.16889
- By:
- Publication type:
- Article
Use of ixazomib, lenalidomide and dexamethasone in patients with relapsed amyloid light‐chain amyloidosis.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 4, p. 643, doi. 10.1111/bjh.16401
- By:
- Publication type:
- Article
Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 5, p. 638, doi. 10.1111/bjh.16122
- By:
- Publication type:
- Article
Real world data of the impact of first cycle daratumumab on multiple myeloma and AL amyloidosis services.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 6, p. 936, doi. 10.1111/bjh.14897
- By:
- Publication type:
- Article
Bone Marrow Assessment in Asymptomatic IgM Monoclonal Gammopathies - Reply to Varettoni et al.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 2, p. 302, doi. 10.1111/bjh.13095
- By:
- Publication type:
- Article
Guidelines on the diagnosis and management of Waldenström macroglobulinaemia.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 3, p. 316, doi. 10.1111/bjh.12760
- By:
- Publication type:
- Article
A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocol.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Spinal disease in myeloma: cohort analysis at a specialist spinal surgery centre indicates benefit of early surgical augmentation or bracing.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Managing the cervical spine in multiple myeloma patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The impact of COVID-19 on autologous stem cell transplantation in multiple myeloma: A single-centre, qualitative evaluation study.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 9, p. 7469, doi. 10.1007/s00520-022-07173-5
- By:
- Publication type:
- Article
Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma.
- Published in:
- Health & Quality of Life Outcomes, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1477-7525-12-35
- By:
- Publication type:
- Article
Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma.
- Published in:
- 2014
- By:
- Publication type:
- journal article